Current Report
Filed: 2026-04-09
Key Insights
- Treace Medical Concepts, Inc. announced the departure of its Chief Commercial Officer, Gaetano M. Guglielmino, and plans to redistribute his responsibilities among existing employees.
- The company provided preliminary, unaudited financial results for Q1 2026, including revenue in the range of $47.0 million to $47.2 million and an increase in cash, cash equivalents, and marketable securities of $3.5 million.
- Treace Medical Concepts updated its full-year 2026 revenue guidance to $202 million to $212 million, citing continued case volume growth offset by product and price mix shifts within its bunion portfolio.